Core Insights - The report from Dongxing Securities highlights that Haida Group's market share in the feed industry continues to increase, with both domestic and international growth expected [1] Feed Sales Performance - In the first half of 2025, the company achieved feed sales of 14.7 million tons, including 1.05 million tons for internal breeding use, representing a year-on-year growth of 25% [1] - The increase in exports is nearing the annual target, indicating strong performance in international markets [1] Swine Breeding Strategy - The company employs a light asset operation model focusing on "purchasing piglets, company + family farms, profit locking, and risk hedging," which optimizes breeding costs and contributes significantly to profitability in the first half of 2025 [1] Aquaculture Management - In aquaculture, the company has achieved significant cost reductions through professional management and technological iterations in industrialized shrimp farming [1] Profitability Metrics - The gross profit margin for agricultural product sales steadily increased, reaching 20.26% in the first half of 2025 [1] Future Outlook - The company plans to steadily enhance capacity utilization in the domestic market while actively expanding in overseas markets, aiming to achieve a strategic target of 51.5 million tons by 2030 [1] - The report suggests that the company's feed business is progressing well both domestically and internationally, with animal health and seedling sectors supporting feed operations, and the light asset breeding model mitigating risks, indicating a long-term competitive advantage [1]

东兴证券研报指出，科达利为锂电结构件龙头，拓展人形机器人第二曲线。公司坚持定位于高端市场、采取重点领域的大客户战略，已与CATL、LG、松下等国内外头部电池厂商建立长期稳定合 ...

Core Viewpoint - The article highlights the performance of new IPOs in the A-share market from January to July 2025, indicating a significant increase in both the number of new listings and the total funds raised compared to the same period last year [1]. Group 1: IPO Performance - A total of 59 new companies were listed in the A-share market from January to July 2025, representing an 18.00% increase from 50 companies in the same period last year [1]. - The net fundraising amount for these 59 new listings reached 544.21 billion yuan, which is a 63.83% increase compared to 332.18 billion yuan in the previous year [1]. Group 2: Underwriting Institutions Ranking - 26 underwriting institutions participated in the IPOs of the 59 new companies, with a total of 60 deals due to dual appointments for some companies [2]. - The top three underwriting institutions by the number of deals are: - First: Guotai Junan with 7 deals - Second: Huatai United and CITIC Securities, each with 6 deals [2]. Group 3: Legal and Accounting Firms Ranking - 25 law firms provided legal services for the 59 new IPOs, with the top three being: - First: Shanghai Jintiancheng with 9 deals - Second: Beijing Zhonglun with 6 deals - Third: Guangdong Xinda with 4 deals [5]. - 15 accounting firms provided auditing services for the IPOs, with the top three being: - First: Rongcheng with 13 deals - Second: Lixin and Tianjian, each with 9 deals [5].

Core Viewpoint - Dongxing Securities successfully issued "2025 Technology Innovation Corporate Bonds (First Phase)" with a scale of 1 billion yuan and a term of 3 years at a coupon rate of 1.80%, reflecting strong market recognition of its operational capabilities and future development [1] Group 1: Bond Issuance Details - The bond issuance was met with enthusiastic subscription from market investors, achieving a subscription multiple of 3.94 [1] - The issuance rate is significantly lower than that of similar securities companies' bonds with the same term, indicating market confidence in Dongxing Securities [1] Group 2: Strategic Implications - The bond issuance aligns with the national innovation-driven development strategy, with raised funds earmarked for investment in the technology innovation sector [1] - Dongxing Securities is committed to the "Technology Finance" development concept, demonstrating its determination to support technological innovation and serve the real economy [1] Group 3: Future Plans - The company plans to continue expanding financing channels and optimizing its financing structure to support high-quality development [1] - Dongxing Securities aims to contribute more significantly to the national innovation-driven development strategy [1]

Core Viewpoint - Dongya Pharmaceutical (605177.SH) is expected to report a significant loss in the first half of 2025, with net profit projected to be between -28 million to -35 million yuan, contrasting sharply with a profit of 32.47 million yuan in the same period last year [1][2]. Financial Performance - In 2024, the company reported operating revenue of 1.198 billion yuan, a decrease of 11.66% year-on-year [2]. - The net profit attributable to shareholders was -101 million yuan, representing a year-on-year decline of 183.02% [2]. - The net profit after excluding non-recurring gains and losses was -98.41 million yuan, down 191.03% year-on-year [2]. - The net cash flow from operating activities was -157 million yuan [2]. Shareholder Structure - The actual controllers of Dongya Pharmaceutical are Chi Zhengming and Chi Cheng, who together hold significant voting rights in the company [1]. - Chi Zhengming directly owns 41.06% of the shares, while Chi Cheng holds 6.79% directly and has additional influence through a partnership [1]. Fundraising and Use of Proceeds - Dongya Pharmaceutical has raised a total of 1.574 billion yuan through two fundraising rounds since its listing [4]. - The company raised 688 million yuan through the issuance of convertible bonds, with a net amount of approximately 680 million yuan after deducting issuance costs [3]. - The funds raised are allocated for projects including the production of key intermediates for cephalosporin antibiotics and upgrading raw material production [2].

2022年，华夏航空非公开发行A股股票。经中国证券监督管理委员会《关于核准华夏航空股份有限公司 非公开发行股票的批复》(证监许可[2022]1662号)的核准，公司向特定对象非公开发行人民币普通股不 超过304,070,293股，每股面值为人民币1.00元，募集资金总额不超过243,500万元。公司实际非公开发行 A股股票264,673,906股，每股发行价格为人民币9.20元，募集资金总额为人民币2,434,999,935.20元，扣 除发行费用人民币25,397,899.32元(不含税)后，募集资金净额为人民币2,409,602,035.88元。立信会计师 事务所(特殊普通合伙)已于2022年11月04日对公司非公开发行A股股票的募集资金到位情况进行了审 验，并出具了《华夏航空股份有限公司非公开发行人民币普通股(A股)实收股本的验资报告》(信会师报 字[2022]第ZK10390号)。 经计算，华夏航空上述三次募集资金总额为406,091.99万元。 中国经济网北京7月28日讯华夏航空（002928）(002928.SZ)今日收报8.55元，跌幅2.40%。目前该股处于 破发状态。 华夏航空于2018年3 ...

Group 1 - The second "Golden Unicorn Best Investment Advisor" selection is underway, focusing on identifying outstanding investment advisors in wealth management [1] - The weekly ranking data from July 14 to July 20 shows that Wang Weilong from Bank of China Securities achieved the highest weekly return of 20.22% in stock simulation trading [1][2] - In the ETF simulation trading group, Sun Baoyan from Xinda Securities topped the list with a weekly return of 10.81% [2][3] Group 2 - In the public fund simulation configuration group, Sun Baoyan also led with a weekly return of 10.91%, followed by He Weidong from Dongxing Securities with 5.88% [3][5] - The social service evaluation highlights top advisors based on their IP homepage and simulated portfolio heat values, with Mei Xingxia from Dongfang Securities leading in IP homepage heat value [11]

查看更多考评等级 2019年7月22日，定位"硬科技"的科创板正式开市，也标志着注册制试点落地。截至2025年7月22日，科创板累计有591家公司上市（含已退市两家），IPO募 集资金合计9271.56亿元，总市值超过7万亿元。科创板显著优化了A股市场行业结构，成为关键核心技术攻关新型举国体制的重要平台。 分券商看，共有65家券商为591家科创板企业提供承销保荐服务，其中中信证券承销数量最多，为99家（含联合承销，下同）；中金公司、中信建投、原海 通证券、华泰联合分别以70家、64家、62家、55家的承销数量位列第二至五位。如果将原国泰君安和海通证券合并计算，国泰海通IPO承销数量为112家， 排名第一。 | | | 科创板开市6周年IP0承销情况 | | | --- | --- | --- | --- | | 序号 | ·· | 募集资金(亿元) 承销家数 | TT | | | 国泰海通 | 2,137.77 | 112 | | 2 | 中信证券 | 1,670.69 | ਰੇਰੇ | | 3 | 中等公司 | 1,302.54 | 70 | | ব | 中信建投证券 | 880.15 | ୧4 | | ട ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：601198 证券简称：东兴证券 公告编号：2025-030 东兴证券股份有限公司 2025 年度第二期短期融资券发行结果公告 东兴证券股份有限公司2025年度第二期短期融资券已于2025年7月23日发行 完毕，相关发行情况如下： | 债券名称 | | | 东兴证券股份有限公司 | | 2025 年度第二期短期融资券 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 债券简称 | 25 | 东兴证券 | | CP002 | 债券代码 | 072510138 | | | | | 发行日 | 2025 | 年 7 | 月 22 | 日 | 起息日 | 年 2025 | 月 7 | 23 | 日 | | 兑付日 | 2026 | 年 5 | 月 22 | 日 | 期限 | 303 天 | | | | | 计划发行总额 | 人民币 | 10 | 亿元 | | 实际发行总额 | 人民 ...

Core Viewpoint - The evaluation results of the securities companies' practice quality for the second quarter of 2025 have been released, highlighting significant changes in the rankings of the top ten firms, with Shenwan Hongyuan taking the lead [1][2]. Group 1: Evaluation Results - A total of 103 securities firms were evaluated, with Shenwan Hongyuan scoring 149.30 to rank first [1][2]. - The top ten firms also include Guotou Securities, Dongxing Securities, CITIC Jianan, CITIC Securities, Kaiyuan Securities, Guotai Junan, Guosen Securities, Huatai Securities, and Galaxy Securities [1][2]. - Compared to the first quarter, Shenwan Hongyuan rose from sixth to first place, while Guotai Junan entered the top ten after merging [2]. Group 2: Business Performance - In the area of sponsorship business quality scores at the Beijing Stock Exchange, Shenwan Hongyuan, Guotou Securities, and Dongxing Securities tied for first with a score of 16 [2]. - In the M&A business quality scores, Shenwan Hongyuan and Dongxing Securities both scored over 12 [2]. - In market-making business quality, CITIC Securities led with a score of 4.92 [2]. Group 3: Compliance Issues - Six securities firms were recorded with negative practice quality behaviors, involving issues in information disclosure and compliance [3]. - Specific penalties included public reprimands, warning letters, and requests for written commitments from involved parties [3]. - A case highlighted involved a company failing to disclose accurate sales agreements, leading to warnings for both the company and its sponsor [3]. Group 4: Information Disclosure Standards - In the first half of 2025, the Beijing Stock Exchange received applications from 115 companies for public offerings, with 6 successfully listed, raising a total of 1.923 billion yuan [4]. - The exchange emphasized the importance of accurate and complete information disclosure, warning that errors could lead to regulatory actions [5]. - The standards for listing have not changed, and companies must meet all requirements to apply for public offerings [4][5].